Successful Application of Stereotactic Body Radiation Therapy for Ventricular Tachycardia Substrate in a Patient With Nonischemic Cardiomyopathy

Cardiac stereotactic body radiotherapy (SBRT) has been gaining attention as a potential treatment for patients with ventricular tachycardia (VT). Here, we describe a nonischemic patient with severe heart failure and VTs originating from the deep anteroseptal substrate that was refractory to standard...

Full description

Saved in:
Bibliographic Details
Published inThe American journal of cardiology Vol. 184; pp. 149 - 153
Main Authors Nasu, Toshihiro, Toba, Masahiro, Nekomiya, Nobuyoshi, Itasaka, Ryo, Mafune, Shoh, Nakata, Takeo, Ikeda, Hikaru, Yokoshiki, Hisashi
Format Journal Article
LanguageEnglish
Published New York Elsevier Inc 01.12.2022
Elsevier Limited
Subjects
Ablation
Cardiac arrhythmia
Cardiomyopathy
Catheters
College professors
Congestive heart failure
Ejection fraction
Fistula
Heart failure
Medical instruments
Morphology
Patients
Planning
Radiation
Radiation therapy
Respiration
Substrates
Tachycardia
Ventricle
Work stations
Palo Alto California
United States > US
California
Online AccessGet full text

Cover

More Information
Summary:Cardiac stereotactic body radiotherapy (SBRT) has been gaining attention as a potential treatment for patients with ventricular tachycardia (VT). Here, we describe a nonischemic patient with severe heart failure and VTs originating from the deep anteroseptal substrate that was refractory to standard and bipolar catheter ablations, and was successfully managed with SBRT. In conclusion, anteroseptal VTs resistant to catheter ablation in severe nonischemic heart failure might be an indication for cardiac SBRT as palliative therapy.
ISSN:0002-9149
1879-1913
DOI:10.1016/j.amjcard.2022.08.017